Patents by Inventor Leif Honda

Leif Honda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140296481
    Abstract: Methods for the determination of renal failure, especially chronic renal failure and acute kidney injury, by measurement of peptide or protein biomarkers are described. The methods are useful to determine stages of renal failure, especially the early stages such as stage 1, 2, and 3 of chronic renal failure and stages R and I of acute kidney injury. Furthermore there are described peptides and test kits used in the invention. The described methods are intended to replace or complement the measurement of creatinine and/or cystatin C and/or NGAL for diagnosis of renal failure.
    Type: Application
    Filed: February 18, 2014
    Publication date: October 2, 2014
    Applicant: PXBiosciences LLC
    Inventors: Harald TAMMEN, Leif HONDA, Michael JURGENS, Andrew PECK
  • Patent number: 8673574
    Abstract: Methods for the determination of renal failure, especially chronic renal failure and acute kidney injury, by measurement of peptide or protein biomarkers are described. The methods are useful to determine stages of renal failure, especially the early stages such as stage 1, 2, and 3 of chronic renal failure and stages R and I of acute kidney injury. Furthermore there are described peptides and test kits used in the invention. The described methods are intended to replace or complement the measurement of creatinine and/or cystatin C and/or NGAL for diagnosis of renal failure.
    Type: Grant
    Filed: August 20, 2009
    Date of Patent: March 18, 2014
    Assignee: PxBioSciences LLC
    Inventors: Harald Tammen, Leif Honda, Michael Jurgens, Andrew Peck
  • Publication number: 20100190164
    Abstract: Methods for the determination of renal failure, especially chronic renal failure and acute kidney injury, by measurement of peptide or protein biomarkers are described. The methods are useful to determine stages of renal failure, especially the early stages such as stage 1, 2, and 3 of chronic renal failure and stages R and I of acute kidney injury. Furthermore there are described peptides and test kits used in the invention. The described methods are intended to replace or complement the measurement of creatinine and/or cystatin C and/or NGAL for diagnosis of renal failure.
    Type: Application
    Filed: August 20, 2009
    Publication date: July 29, 2010
    Inventors: Harald Tammen, Leif Honda, Michael Jurgens, Andrew Peck